Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

Since the existence of the oligometastatic disease state was posited three decades ago,1 there has been interest in ...

Phase 2 data support the use of SBRT in patients with CRPC who have 1-5 metastatic sites, according to researchers.

The crossover of the bevacizumab and panitumumab survival curves in the PARADIGM study: A clue to time-related effects of bevacizumab on the risk of tumor progression. Risk of peritoneal recurrence ...

SBRT provided better local tumor control, while both treatments were effective and well-tolerated. SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors ...

Tumor ablation, and ablative radiation therapies such as stereotactic body radiation therapy (SBRT), are mainstays ... investigator-initiated trials in patients with advanced cancer suggest ...

While radiation therapy has been in use for more than 100 years, innovations including linear accelerators, imaging, and AI have made this treatment exceptionally targeted and highly effective.

The SBRT arm had significantly prolonged radiographic progression-free survival (rPFS) compared with patients who received enzalutamide plus ADT alone: 4.6 vs 2.3 years, for a significant 52% ...

Furthermore, the addition of SBRT to sorafenib was associated with clinically important improvements in overall survival (OS) for patients with locally advanced HCC. These results were recently ...

MANSFIELD – OhioHealth’s Radiation Oncology program has been named a 2024 Human Experience (HX) Guardian of Excellence Award winner by Press Ganey, the global leader in healthcare experience solutions ...